Cell and gene data innovation and multi-stakeholder data transfer
Plan, capture and utilize RWE and RWD across the value chain to optimize commercial strategy.
FREE WEBINAR · Thursday July 29, 2021 · 11am (EST) / 4pm (BST) / 5pm (CET)
For those working on potentially life-changing cell and gene therapies – whether developing the therapy itself, executing clinical trials, preparing to launch, manufacturing, or administering – the requirements of these complex and delicate value chains is something pharma has traditionally never seen before. Important data often owned by treatment centres, is needed by manufacturers to prepare capacity, by developers to engage payers and patients, as well as required by regulators for approval and post-marketing.
To achieve commercial success, the stakeholders need to come together very early on to establish an end-to-end data integration framework that enables the seamless onboarding of new treatment centres, CDMOs and capacity builders, reduces delivery costs through data insights, infuses the science with patient insights (RWD), and streamlines patient scheduling – all while avoiding the usual frictions experienced in multi-stakeholder value chains, where differing needs and approaches collide.
In this free to attend, live webinar, cell and gene trailblazers Novartis, BMS and Salesforce will share their lessons learned in innovating data sharing approaches and achieving multi-stakeholder alignment. You will learn how to:
-
Reimagine the technology: digitally transforming existing data integration models for cell and gene therapies
-
Reach for the future together: develop a multi-stakeholder strategy collaboratively, that aligns on needs and capabilities
-
Cross-capture and utilize data flow from R&D through to launch to win the marketplace with science anddata
-
Prepare for and address the major barriers to success: such as infrastructure non-readiness, digitally siloed stakeholders, underdeveloped partnerships, and data illiteracy
-
Turn data in to true insights: that enhance the science, reduce the cost of deliver, improve commercial decision making and elevate the patient experience
PANELISTS:
-
Augusto Penjasoff, Business Partner, Global Cell Therapy IT Head, Bristol Myers Squibb
-
Curt Fitzgerald, Director – Service Delivery – Cell & Gene Therapy, Novartis
-
Gary Gabriel, Global Advisor for Healthcare and Life Sciences, Tableau, Salesforce
-
MODERATOR: Beth Hayes, HLS Business Consulting – Pharma Lead, Salesforce
